A double-blind, placebo-controlled, randomized, multi-center study of pramipexole in advanced Parkinson's disease

European Journal of Neurology ◽

10.1046/j.1468-1331.1998.530235.x ◽

1998 ◽

Vol 5 (3) ◽

pp. 235-242 ◽

Author(s):

L. Wermuth ◽

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo ◽

Multi Center Study ◽

Download Full-text

Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study

Journal of Neurology Neurosurgery & Psychiatry ◽

10.1136/jnnp.66.4.436 ◽

1999 ◽

Vol 66 (4) ◽

pp. 436-441 ◽

Author(s):

M M Pinter ◽

O Pogarell ◽

W H Oertel

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Multicentre Study ◽

Dopamine Agonist ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo

Download Full-text

Clinical evaluation of pramipexole in advanced Parkinson's disease: Results of a double-blind, placebo-controlled, parallel-group study

Neurology ◽

10.1212/wnl.49.1.162 ◽

1997 ◽

Vol 49 (1) ◽

pp. 162-168 ◽

Author(s):

A. Lieberman ◽

A. Ranhosky ◽

D. Korts

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Clinical Evaluation ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Download Full-text

Rotigotine transdermal patch in Chinese patients with advanced Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study

Parkinsonism & Related Disorders ◽

10.1016/j.parkreldis.2017.08.015 ◽

2017 ◽

Vol 44 ◽

pp. 6-12 ◽

Author(s):

Zhen-Xin Zhang ◽

Chun-Feng Liu ◽

En-Xiang Tao ◽

Ming Shao ◽

Yi-Ming Liu ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Chinese Patients ◽

Transdermal Patch ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo ◽

Pivotal Study ◽

Rotigotine Transdermal Patch

Download Full-text

Subcutaneous apomorphine in patients with advanced Parkinson's disease: A dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose

Journal of the Neurological Sciences ◽

10.1016/j.jns.2007.03.013 ◽

2007 ◽

Vol 258 (1-2) ◽

pp. 137-143 ◽

Author(s):

Rajesh Pahwa ◽

William C. Koller ◽

Richard M. Trosch ◽

James H. Sherry

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Single Dose ◽

Dose Escalation ◽

Dose Escalation Study ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo ◽

Subcutaneous Apomorphine

Download Full-text

Transdermal rotigotine in advanced Parkinson’s disease: a randomized, double-blind, placebo-controlled trial

Journal of Neurology ◽

10.1007/s00415-014-7427-3 ◽

2014 ◽

Vol 261 (10) ◽

pp. 1887-1893 ◽

Author(s):

Masahiro Nomoto ◽

Yoshikuni Mizuno ◽

Tomoyoshi Kondo ◽

Kazuko Hasegawa ◽

Miho Murata ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Gabapentin in traumatic nerve injury pain: a randomized, double-blind, placebo-controlled, cross-over, multi-center study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1141888.598992 ◽

2009 ◽

Author(s):

Claudia Sommer

Keyword(s):

Nerve Injury ◽

Double Blind ◽

Double Blind Placebo ◽

Multi Center Study ◽

Download Full-text

Faculty Opinions recommendation of Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737065221.793569342 ◽

2020 ◽

Author(s):

Joseph Jankovic ◽

Arjun Tarakad

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.8286956.8718054 ◽

2011 ◽

Author(s):

Irene Litvan ◽

Rita Simoes

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Depressive Symptoms ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.8638956.9139058 ◽

2011 ◽

Author(s):

John O'Brien ◽

John-Paul Taylor

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Dementia With Lewy Bodies ◽

Controlled Trial ◽

Lewy Bodies ◽

Parkinson’S Disease Dementia ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Pingchan granule for depressive symptoms in parkinson’s disease: A randomized, double-blind, placebo-controlled trial

Journal of Integrative Medicine ◽

10.1016/j.joim.2020.12.006 ◽

2020 ◽

Author(s):

Si-chun Gu ◽

Jie Zhou ◽

Qing Ye ◽

Can-xing Yuan

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Depressive Symptoms ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text